DK1724342T3 - Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli - Google Patents
Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coliInfo
- Publication number
- DK1724342T3 DK1724342T3 DK05709866.7T DK05709866T DK1724342T3 DK 1724342 T3 DK1724342 T3 DK 1724342T3 DK 05709866 T DK05709866 T DK 05709866T DK 1724342 T3 DK1724342 T3 DK 1724342T3
- Authority
- DK
- Denmark
- Prior art keywords
- spaa
- erysipelothrix rhusiopathiae
- surface protective
- protective antigen
- protein
- Prior art date
Links
- 241000186810 Erysipelothrix rhusiopathiae Species 0.000 title abstract 3
- 241000588724 Escherichia coli Species 0.000 title abstract 3
- 101710194807 Protective antigen Proteins 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 210000003000 inclusion body Anatomy 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004053882 | 2004-02-27 | ||
| PCT/JP2005/001814 WO2005083072A1 (ja) | 2004-02-27 | 2005-02-08 | 大腸菌における豚丹毒菌表層防御抗原変異体の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1724342T3 true DK1724342T3 (da) | 2011-07-18 |
Family
ID=34908767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05709866.7T DK1724342T3 (da) | 2004-02-27 | 2005-02-08 | Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8277820B2 (da) |
| EP (1) | EP1724342B1 (da) |
| JP (1) | JP4755977B2 (da) |
| CN (1) | CN101031647B (da) |
| AT (1) | ATE513909T1 (da) |
| DK (1) | DK1724342T3 (da) |
| ES (1) | ES2367128T3 (da) |
| WO (1) | WO2005083072A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008054673A (ja) * | 2006-08-03 | 2008-03-13 | Hokkaido Univ | 組み換え蛋白質の製造方法 |
| JP2014000016A (ja) * | 2012-06-15 | 2014-01-09 | National Agriculture & Food Research Organization | 豚丹毒菌の新規な抗原タンパク質、その遺伝子、及び組換えベクターとその利用 |
| KR101535704B1 (ko) * | 2012-12-28 | 2015-07-27 | 한국생명공학연구원 | 항원성 단백질 고정화를 통한 돈단독 백신 제조방법 |
| CN103941002B (zh) * | 2013-03-15 | 2016-03-16 | 河南省农业科学院 | 猪丹毒杆菌抗原快速检测试纸条 |
| CN103397023B (zh) * | 2013-08-20 | 2014-12-10 | 广东温氏食品集团股份有限公司 | 猪丹毒杆菌的pcr引物及其应用 |
| CN106995489B (zh) * | 2016-01-22 | 2018-11-06 | 华中农业大学 | 一种猪链球菌截短蛋白Sao及应用 |
| TWI638827B (zh) | 2017-07-25 | 2018-10-21 | 國立屏東科技大學 | 交叉保護性重組抗原及含彼之動物疫苗組成物 |
| CN110183520B (zh) * | 2019-05-25 | 2022-12-20 | 青岛易邦生物工程有限公司 | 一种猪丹毒SpaA蛋白及其在制备疫苗中的应用 |
| CN113388624A (zh) * | 2020-09-21 | 2021-09-14 | 浙江理工大学 | 一种猪丹毒SpaA抗原蛋白及其优化克隆的制备方法 |
| CN115850404B (zh) * | 2022-12-13 | 2024-02-09 | 中国兽医药品监察所 | 一种串联优势表位的重组猪丹毒杆菌表面保护抗原a及其应用 |
| CN116284274A (zh) * | 2022-12-13 | 2023-06-23 | 中国兽医药品监察所 | 一种重组猪丹毒杆菌表面抗原SpaA蛋白及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1040923A (zh) * | 1989-06-08 | 1990-04-04 | 易超伦 | 血清组合物及其配制方法 |
| JPH0630771A (ja) | 1992-07-14 | 1994-02-08 | Ajinomoto Co Inc | バクテリアルトランスグルタミナーゼの製造法及び関連物 |
| AU3364000A (en) * | 1999-02-10 | 2000-08-29 | Rockefeller University, The | Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope |
| JP3072345B1 (ja) | 1999-03-31 | 2000-07-31 | 農林水産省家畜衛生試験場長 | 豚丹毒菌の組換えサブユニットワクチン |
| CN1281731A (zh) * | 1999-07-22 | 2001-01-31 | 李六金 | 猪用免疫球蛋白注射液 |
| JP3532510B2 (ja) | 2000-07-21 | 2004-05-31 | 独立行政法人農業・生物系特定産業技術研究機構 | 組換え豚丹毒菌防御抗原の回収精製法 |
| JP2002306163A (ja) | 2001-04-11 | 2002-10-22 | Chemo Sero Therapeut Res Inst | 大腸菌を宿主とする遺伝子組換えヒトトロンビンの調製方法 |
-
2005
- 2005-02-08 DK DK05709866.7T patent/DK1724342T3/da active
- 2005-02-08 WO PCT/JP2005/001814 patent/WO2005083072A1/ja active Application Filing
- 2005-02-08 ES ES05709866T patent/ES2367128T3/es active Active
- 2005-02-08 AT AT05709866T patent/ATE513909T1/de not_active IP Right Cessation
- 2005-02-08 JP JP2006510389A patent/JP4755977B2/ja not_active Expired - Fee Related
- 2005-02-08 US US10/590,896 patent/US8277820B2/en active Active
- 2005-02-08 EP EP05709866A patent/EP1724342B1/en active Active
- 2005-02-08 CN CN2005800135953A patent/CN101031647B/zh active Active
-
2010
- 2010-11-18 US US12/949,606 patent/US8361749B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1724342A1 (en) | 2006-11-22 |
| US20080286309A1 (en) | 2008-11-20 |
| US8361749B2 (en) | 2013-01-29 |
| EP1724342A4 (en) | 2008-08-13 |
| ES2367128T3 (es) | 2011-10-28 |
| US20110059021A1 (en) | 2011-03-10 |
| ATE513909T1 (de) | 2011-07-15 |
| JPWO2005083072A1 (ja) | 2007-11-22 |
| EP1724342B1 (en) | 2011-06-22 |
| CN101031647B (zh) | 2010-12-29 |
| CN101031647A (zh) | 2007-09-05 |
| WO2005083072A1 (ja) | 2005-09-09 |
| US8277820B2 (en) | 2012-10-02 |
| JP4755977B2 (ja) | 2011-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1724342T3 (da) | Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli | |
| NL300897I2 (nl) | Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit | |
| DK1185691T3 (da) | Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf | |
| ATE490262T1 (de) | Abschwächung der immunogenizität von fusionsproteinen | |
| WO2002072036A3 (en) | Compositions and methods comprising west nile virus polypeptides | |
| DK1487485T3 (da) | Imidazoquinolinadjuvanser til DNA-vacciner | |
| WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
| CY1105685T1 (el) | Συνδεομενα με ογκους αντιγονικα παραγωγα απο την οικογενεια mage, και ακολουθιες νουκλεϊκων οξεων που τα κωδικοποιουν, χρησιμοποιουμενα στην παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο | |
| DK1090039T3 (da) | Peptidsammensætning som immunogen til behandling af allergi | |
| WO2006090385A3 (en) | Protease inhibitors and method of screening thereof | |
| WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
| DK1349944T3 (da) | Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens | |
| DK2289533T3 (da) | Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider | |
| ATE551069T1 (de) | Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung | |
| WO2005035558A3 (en) | Piscirickettsia salmonis antigens and use thereof | |
| EE200500012A (et) | Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks | |
| ATE469170T1 (de) | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 | |
| DE60316189D1 (de) | P153- und p156-antigene zur immundiagnose von ehrlichiose in hunden und menschen und verwendungen davon | |
| DE60336588D1 (de) | Verbesserte anthraximpfstoffe und abgabeverfahren | |
| WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
| WO2006113782A3 (en) | Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof | |
| DK1416956T3 (da) | Autologe T-celle-vaccinematerialer samt fremgangsmåde til deres fremstilling | |
| PT1962889E (pt) | Polipéptido imunogénico formado por péptidos crípticos optimizados provenientes de antigénios tumorais, e suas utilizações | |
| WO2009083968A8 (en) | Novel protein | |
| WO2007101948A3 (fr) | Nouveaux vaccins destines au traitement ou a la prevention des infections par parasites de la famille des taenidae et en particulier du genre echinococcus |